Proteomics Market

Proteomics Market by Instrument (Spectroscopy, Chromatography, Electrophoresis, Microfluidics, X-ray Crystallography), Reagents, Services & Software (Protein Identification, Characterization, Bioinformatics), Application - Global Forecast to 2024

Report Code: BT 2341 Oct, 2019, by marketsandmarkets.com
Updated date -

MarketsandMarkets forecasts the Proteomics market to grow from USD 19.49 billion in 2019 to USD 38.74 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 14.7% during the forecast period. An increase in the research activity, especially in the area of personalized medicine and drug discovery is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are also propelling the growth of the proteomics market. The objective of the report is to define, describe, and forecast the proteomics market size based on instrumentation technology, reagent, service & software, application, and region.

Proteomics Market

By instrumentation technology, the protein fractionation segment is expected to grow at the highest growth rate during the forecast period

Among the instrumentation technologies used in proteomics, the protein fractionation segment is expected to grow at the highest CAGR during the forecast period. This growth is attributed to the benefits of effectively separating thousands of proteins in a complex structure and high resolution. The need for the analysis of complex mixtures comprising proteins is increasing in proteomics research; this serves to drive the market demand for protein fractionation systems.

The spectroscopy and protein microarrays segments are also expected to grow at high CAGRs during the forecast period. The spectroscopy segment is categorized into mass spectroscopy, NMR spectroscopy, and CD spectroscopy. The NMR spectroscopy market is expected to propel in the coming years with its use in structural proteomics. On the other hand, the protein microarrays segment is further segmented into biochips and microarray instruments. The protein chips market is expected to show growth with its increasing use in studying protein interactions with other ligands.

By reagent, the protein fractionation reagents segment to record the highest CAGR during the forecast period

The protein fractionation reagents segment is expected to witness a faster growth rate in this market. This can be attributed to the increasing need for protein separation from complex mixtures, thereby moving towards effective analysis

By service & software, the core proteomics services segment to accounted for the largest share of the market

The core proteomics services accounted for the largest share of the global proteomics market. These services form the basis of proteomics and are highly adopted at every stage of the proteome analysis. In addition, a large number of services are being outsourced, which is driving their growth.

By application, the clinical diagnostics segment accounted for the largest share of the market

The clinical diagnostics segment accounted for the largest share of the proteomics market. This can be attributed to the increased understanding of the relevance of investigating and understanding patterns of protein expression for disease diagnostics and drug development. Moreover, proteomic technologies such as tandem MS and LC have proved to be efficient for the identification of proteins, even in highly complex biological fluids such as urine.

North America to account for the largest market size during the forecast period.

North America is expected to hold the largest market size in the proteomics market during the forecast period, followed by the European region. The highest market share of North America can be attributed to the increasing investments in the development of structure-based drug designs, growing research in the fields of omics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment. On the other hand, the Asia Pacific market is expected to witness the highest growth during the forecast period, primarily due to the increasing investments by governments and industries, growing biotechnology research, and rising awareness on personalized therapeutics.

Proteomics Market

Market Dynamics

Driver: Increasing demand for personalized medicine

Personalized medicine, which has become a core area of research in the healthcare industry, has entered mainstream clinical practice and is changing the way many diseases are identified, classified, and treated. These advancements are particularly evident in the area of oncology. According to the Personalized Medicine Coalition report (2017), the number of personalized drugs, treatments, and diagnostic products has increased since 2006, and this trend is expected to continue in the coming years. Moreover, biopharmaceutical companies have nearly doubled their R&D investments in personalized medicine over the last five years; this is further expected to increase by 33% over the next five years. The progress of genomics in achieving personalized therapy is limited owing to the inability of genetics to predict the diversity of protein expression patterns, modifications, or protein interactions following translation. Therefore, studying the proteomes of individuals and incorporating this information with genetic data has aided the advancement of personalized medicine. With the growing prominence of personalized medicine, there is an increased demand for rapid, highly sensitive, and quantitative methods to analyze proteins and related post-translational modifications in clinical specimens. Advances in proteomic technologies have made important contributions to the development of personalized medicine by facilitating the detection of protein biomarkers, proteomics-based molecular diagnostics, as well as protein biochips & pharmacoproteomics.

The demand for protein therapeutics, including hormones, vaccines, monoclonal antibodies, blood factors, and therapeutic enzymes, has increased in the last few years. This growing demand for protein therapeutics and personalized medicine, coupled with the development of newly engineered proteins, is expected to increase the uptake of proteomic technologies as diagnostic tools and in the drug development process, propelling the growth of the overall market.

Restraint: High cost of instruments

With the widespread implementation of novel applications, the use of proteomics research extends all the way from the discovery of novel drugs, vaccines, and diagnostic targets; characterization of protein-based products; toxicology; and identification of surrogate markers of activity in clinical research to the ability to provide information on the mechanisms of drug action. This requires the use of different types of platforms and instruments as well as laboratory documentation systems, contributing to the high cost of protein analytics. Advancements in various instrumentation have led to high prices in comparison to traditional ones owing to their expensive development process. For instance, the price of mass spectrometers can range from USD 20,000 to USD 300,000, which makes this technology highly costly for small-scale pharma companies and academic institutions. Also, the price of ion exchange chromatography with fractions collection is around USD 250 per sample as per proteomics and mass spectrometry services from Cornell University. Peptide quantitation by extracted ion chromatograms costs around USD 160 per sample. Such high prices of instruments and reagents make it difficult for developing countries to venture into the field of proteomics. In addition, the outcome of the studies may not always be as expected, leading to unsatisfactory results or process re-runs, increasing the overall cost of the study. Maintenance of these instruments is also a costly affair, which involves spares, chemicals, consumables, and timely servicing.

Opportunity: Growing prominence of nanoproteomics

The rapidly growing field of proteomics has excelled in various life disciplines but not without challenges such as the analysis of vast PTMs, dynamic range of molecules, and biological complexities. These challenges are being overcome with the use of nanotechnology. The field of nanotechnology has been associated with several proteomics applications such as phosphoproteomics/metal oxide nanoparticles, nanostructure surfaces for protein separation, and analytical detection of biomarker proteins using array techniques. This has led to the emergence of nanoproteomics. This technique is utilized as a complementary component to revolutionize proteomics through different kinds of nanotechnology applications, including nanoporous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures. The advances in this field have begun to allow researchers to identify low-abundance proteins in samples through techniques that rely on both nanoparticles and nanoscale devices. Nanoproteomics is also being applied in the discovery of next-generation biomarkers and to aid in peptide mass fingerprinting to quantify different protein concentrations. Currently, a number of research programs are focusing on increasing the applications of nanotechnology to improve the productivity, efficiency, accuracy, and precision of the proteomics technologies being used.

Challenge: Data management in proteomics research

Proteomics is a rapidly expanding field, aided by improvements in instrumentation accuracy and sensitivity, size, and affordability. However, with the increase in proteome analysis, there is an inevitable increase in the volume of data generated. There are various challenges associated with large data volumes; these include issues related to:

• Data Storage: While technological advancements have enabled automation in the data storage process by creating databases, there is a struggle to understand the full potential of such datasets and to keep pace with data output. • Data Integration: One major challenge is the integration of new and existing proteome data with other valuable omics and metadata. Currently, there is no optimal or standardized approach to enable data integration due to inconsistencies in annotation, reporting of datasets, and outputs of analysis pipelines. Moreover, proteome coverage tends to be poorer than other omics data types. • Unifying Data Repositories: While the amount of proteomic data generated is growing, the amount cataloged in publicly available repositories does not reflect this influx.

Proteomics Market

Scope of the Report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Values (USD)

Segments covered

Instrumentation Technology, Reagent, Service and Software, Application, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Companies covered

Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Luminex Corporation (US), Bruker Corporation (US), Merck KGaA (Germany), Waters Corporation (US), PerkinElmer, Inc. (US), Creative Proteomics (US), and Promega Corporation (US)

The research report categorizes the proteomics market to forecast the revenues and analyze the trends in each of the following sub-segments:

Proteomics Market, by Instrumentation Technology

  • Protein Microarrays
    • Biochips               
      • Protein Chips
      • Lab-on-Chips (Microfluidics)
    • Microarray Instruments
      • Integrated Systems
      • Arrayers
      • Microarray Scanners
  • Spectroscopy
    • Mass Spectroscopy
    • NMR Spectroscopy
    • CD Spectroscopy
  • X-ray Crystallography
  • Chromatography
    • HPLC
    • Ion Chromatography
    • Affinity Chromatography
    • Supercritical Fluid Chromatography
  • Electrophoresis
    • Gel Electrophoresis
    • Capillary electrophoresis
  • Surface Plasmon Resonance
  • Protein Fractionation

Proteomics Market, by Reagent

  • Protein Microarray Reagents
  • Spectroscopy Reagents
  • X-ray Crystallography Reagents
  • Chromatography Reagents
  • Electrophoresis Reagents
  • Immunoassay Reagents
  • Protein Fractionation Reagents

Proteomics Market, by Service and Software

  • Core Proteomics Services
    • Protein Identification Services
    • Protein Separation Services
    • Protein Sequencing Services
    • Quantitative Proteomic Services
    • Protein Characterization Services
    • Custom Assay Services
  • Bioinformatics Software & Services
    • Bioinformatics Databases
    • Bioinformatics Tools
    • Bioinformatics Services

Proteomics Market, by Application

  • Drug Discovery
    • Target Discovery
    • Lead Identification
    • Lead Optimization
    • Preclinical Studies
  • Clinical Diagnostics
    • Cancer
    • Infectious Diseases
    • Diabetes
    • Neurological Disorders
    • Immune Diseases
    • Cardiovascular Diseases
    • Others
  • Other Applications

Proteomics Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

 Key Market Players

  1. Thermo Fisher Scientific, Inc. (US)
  2. Agilent Technologies, Inc. (US)
  3. Danaher Corporation (US)
  4. Merck KGaA (Germany)
  5. Waters Corporation (US)

Thermo Fisher Scientific was one of the leading players in the proteomics market. The company is known for its diversified product offerings in the proteomics arena ranging from protein expression, purification and isolation kits; electrophoresis instruments and reagents; protein assays and analysis; labeling and crosslinking; mass spectrometry instruments; and protein purification & analytics interactive tools along with a wide range of customization services. Owing to its strong sales and distribution network, the company has a significant global footprint. Additionally, the large number of production sites gives it a competitive advantage over other players in the proteomics market.

Recent Developments

  • In October 2018, Waters Corporation launched its RenataDX Screening System
  • In October 2018, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.
  • In July 2018, Thermo Fisher Scientific, Inc. (US) launched the Quadrupole-Orbitrap Mass Spectrometer
  • In May 2018, Agilent acquired Advanced Analytical Technologies, Inc. (US). This acquisition enhanced Agilent’s technology base to provide customers with a comprehensive set of solutions for next-generation sequencing workflows.
  • In May 2018, PerkinElmer acquired Shanghai Spectrum Instruments Co., Ltd. (SSI) (China), one of the leading manufacturers of analytical instruments in China. This will help the firm in building its footprint in China through SSI’s localized leading market position.

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends in the proteomics market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Content

1 Introduction

    1.1 Objectives of  The Study  
    1.2 Market Definition  
    1.3 Market Scope  
           1.3.1 Markets Covered 
           1.3.2 Years Considered for The Study 
    1.4 Currency  
    1.5 Stakeholders  
    1.6 Limitations
 
2 Research Methodology  
    2.1 Research Approach  
           2.1.1 Secondary Research 
                    2.1.1.1 Key Data From Secondary Sources 
           2.1.2 Primary Research 
                    2.1.2.1 Key Data From Primary Sources 
                    2.1.2.2 Break Down of  Primaries 
                    2.1.2.3 Key Industry Insights 
    2.2 Market Size Estimation  
    2.3 Data Triangulation Approach  
    2.4 Market Share Estimation  
    2.5 Assumptions for The Study
 
3 Executive Summary
 
4 Premium Insights  
    4.1 Proteomics: Market Overview  
    4.2 Proteomics Market: Geographic Growth Opportunities  
    4.3 Regional Mix: Proteomics Market (2019–2024)  
    4.4 Proteomics Market: Developed Vs. Developing Markets, 2019 Vs. 2024
 
5 Market Overview  
    5.1 Introduction  
    5.2 Market Dynamics  
           5.2.1 Market Drivers 
                    5.2.1.1 Increasing Demand for Personalized Medicine 
                    5.2.1.2 Proteomics Bridges The Gap Between Genomics And Biochemistry 
                    5.2.1.3 Increasing Pharmaceutical And Biotechnology R&D Expenditure And Government Funding for Proteomics 
                    5.2.1.4 Technological Advancements 
           5.2.2 Market Restraints 
                    5.2.2.1 High Cost of  Instruments 
           5.2.3 Market Opportunities 
                    5.2.3.1 Growing Prominence of  Nanoproteomics—The Convergence of  Nanotechnology And Proteomics 
                    5.2.3.2 Personalized Proteomics for Precision Health 
                    5.2.3.3 High Growth Opportunities in Emerging Countries 
           5.2.4 Market Challenges 
                    5.2.4.1 Data Management in Proteomics Research 
                    5.2.4.2 Low Biomarker Discovery-To-Approval Ratio
 
6 Industry Insights  
    6.1 Introduction  
    6.2 Industry Trends  
           6.2.1 Integration of  Omics Data in Biomedical Sciences9 
           6.2.2 Growing Focus On Monitoring Post-Translational Modifications 
           6.2.3 Increasing Uptake of  Label-Free Quantification Techniques 
           6.2.4 Integrating Networks And Proteomics 
    6.3 Unmet Needs Analysis  
           6.3.1 Challenges in Analyzing Low Abundance Proteins
 
7 Proteomics Market, By Instrumentation Technology  
    7.1 Introduction  
    7.2 Spectroscopy  
           7.2.1 Mass Spectroscopy 
                    7.2.1.1 The Ability of  Ms to Identify Small Amounts of  Protein From Increasingly Complex Mixtures is  A Major Factor Driving Its Use in Proteomics 
           7.2.2 Nmr Spectroscopy 
                    7.2.2.1 Nmr Experiments Used to Evaluate The Physical, Chemical, Electronic, And Structural Information of  Proteins 
           7.2.3 Cd Spectroscopy 
                    7.2.3.1 Cd Spectroscopy is   Used to Examine Changes in Secondary Structures of  Protein in Response to Environmental Conditions Or Interactions With Other Molecules 
    7.3 Chromatography  
           7.3.1 Hplc 
                    7.3.1.1 The Two Types of  Hplc Systems Commonly Available in The Market are Split Flow Systems And Non-Split Flow Systems 
           7.3.2 Ion Chromatography 
                    7.3.2.1 Ion Chromatography Is The Most Commonly Used Chromatographic Method for Separating Proteins, Polypeptides, Nucleic Acids, And Other Charged Molecules  
           7.3.3 Affinity Chromatography 
                    7.3.3.1 Affinity Chromatography Can Be Used in Two Ways, Either Through The Enrichment of  A Specific Class of  Proteins Or Depletion of  Certain Types of  Proteins 
           7.3.4 Supercritical Fluid Chromatography 
                    7.3.4.1 Sfc And Mass Spectrometry are Used for The Separation And Analysis of  Integral Membrane Proteins And Hydrophobic Peptides 
    7.4 Electrophoresis  
           7.4.1 Gel Electrophoresis 
                    7.4.1.1 The Most Common Use of  Gel Electrophoresis is   The Qualitative Analysis of  A Complex Mixture of  Proteins 
           7.4.2 Capillary Electrophoresis 
                    7.4.2.1 Ce Coupled With Ms is   Used to Assess The Structure And Identity of  Individual Proteins, Including Intact Proteins Over A Wide Molecular Weight Range 
    7.5 Protein Microarrays  
           7.5.1 Biochips 
                    7.5.1.1 Lab-On-Chips (Microfluidics) 
                               7.5.1.1.1 Loc is   One of  The Fastest Growing Areas of  Microfabrication And Nanotechnology Development 
                    7.5.1.2 Protein Chips 
                               7.5.1.2.1 The Automated, Affordable, And Highly Sensitive Solutions of fered By Protein Chips Give Them A Advantage Over Conventional Protein Analysis Tools 
           7.5.2 Microarray Instruments 
                    7.5.2.1 Integrated Systems 
                               7.5.2.1.1 Integrated Systems are Capable of  Carrying Out The Entire Procedure of  Protein Analysis Without Any Intermediate Steps 
                    7.5.2.2 Microarray Scanners 
                               7.5.2.2.1 Microarray Scanners Find Applications in The Data Analysis of  Proteins, Tissues, And Cells 
                    7.5.2.3 Arrayers 
                               7.5.2.3.1 Technological Advancements Have Made Microarray Spotters Ideal for Large-Scale Arraying Projects 
    7.6 X-Ray Crystallography  
           7.6.1 X-Ray Crystallography Helps in The Measurement of  The 3d Density Distribution of  Electrons in A Crystallized Protein in A Certain Resolution 
    7.7 Surface Plasmon Resonance  
           7.7.1 Spr Imaging Helps Monitor A Range of  Molecular Interactions, Such  as Peptide-Protein, Carbohydrate-Protein, Protein-Protein Binding, And Surface Enzyme Kinetics 
    7.8 Protein Fractionation  
           7.8.1 Protein Fractionation Refers to The Process of  Isolating, Identifying, And Characterizing Various Proteins in A Sample of  Complex Proteome Mixtures
 
8 Proteomics Market, By Reagent  
    8.1 Introduction  
    8.2 Immunoassay Reagents  
           8.2.1 Immunoassay Reagents to Dominate The Market During The Forecast Period 
    8.3 Spectroscopy Reagents  
           8.3.1 The Use of  These Reagents is   Increasing With The Rising Adoption of  Ms Techniques 
    8.4 Chromatography Reagents  
           8.4.1 Increasing Demand for Protein Purification is   Expected to Drive Market Growth 
    8.5 Protein Microarray Reagents  
           8.5.1 Use of  These Reagents Has Increased for Analyzing Protein Interactions 
    8.6 X-Ray Crystallography Reagents  
           8.6.1 Study of  Protein Structural Orientation Forms  an Part of  Crystallography Study 
    8.7 Electrophoresis Reagents  
           8.7.1 Increasing Demand for 2d Electrophoresis is   Driving The Adoption of  These Reagents 
    8.8 Protein Fractionation Reagents  
           8.8.1 Increasing Protein Separation From Complex Mixtures Makes This One of  The Fastest-Growing Segments
 
9 Proteomics Market, By Services & Software  
    9.1 Introduction  
    9.2 Core Proteomics Services  
           9.2.1 Protein Identification Services 
                    9.2.1.1 Protein Identification Services to Dominate The Market During The Forecast Period 
           9.2.2 Protein Characterization Services 
                    9.2.2.1 Characterization Studies Play A Vital Role in Studying Complex Protein Structure, Drug Development, And Ptms 
           9.2.3 Quantitative Proteomics Services 
                    9.2.3.1 Quantitative Proteomics is  Critical for Understanding Protein Expression And Modifications 
           9.2.4 Protein Purification Services 
                    9.2.4.1 Protein Purification Aids in Improving The Overall Proteome Analysis And Depends On The Probable Use of  The Protein 
           9.2.5 Protein Separation Services 
                    9.2.5.1 Separation Plays  an Important Role in The Characterization of  Large-Sized Proteomes 
           9.2.6 Protein Sequencing Services 
                    9.2.6.1 Identification And Characterization of  Ptms is   an Important Area of  Research That Needs Protein Sequencing 
           9.2.7 Custom Assay Services 
                    9.2.7.1 Assays are Adopted to Improve The Validation Or Consistency of  The Protein Analysis Procedures 
    9.3 Bioinformatics Software & Services  
           9.3.1 Bioinformatics Services 
                    9.3.1.1 Bioinformatics Services are Set to Dominate The Market During The Forecast Period 
           9.3.2 Bioinformatics Tools 
                    9.3.2.1 Need for Data Management And Quality Enhancement of  Results Obtained Makes Tools  an Imperative Part of  Proteomics 
           9.3.3 Bioinformatics Databases 
                    9.3.3.1 Databases Majorly Contribute to Storing Proteomics Data Along With Integrating Other Omics Databases
 
10 Proteomics Market, By Application  
     10.1 Introduction  
     10.2 Clinical Diagnostics  
             10.2.1 Cancer 
             10.2.2 Infectious Diseases 
             10.2.3 Diabetes 
             10.2.4 Neurological Disorders 
             10.2.5 Immune Diseases 
             10.2.6 Cardiovascular Diseases 
             10.2.7 Others 
     10.3 Drug Discovery  
             10.3.1 Target Discovery 
             10.3.1 Lead Identification 
             10.3.1 Lead Optimization 
             10.3.1 Preclinical Studies 
     10.4 Other Applications
 
11 Proteomics Market, By Region  
     11.1 Introduction  
     11.2 North America  
             11.2.1 Us 
               11.2.1.1 Us Dominates The North American Proteomics Market
             11.2.2 Canada 
               11.2.2.1 Strong Infrastructure And Availability of  Funding for Biomedical Research Will Support Market Growth
     11.3 Europe  
             11.3.1 Germany 
               11.3.1.1 Germany Holds The Largest Share of  The European Market
             11.3.2 Uk 
               11.3.2.1 The Uk Has Seen A Surge in The Prevalence of  Cancer And Neurological Disorders
             11.3.3 France 
               11.3.3.1 Proteomics Research in France is  Strongly Supported By The Government
             11.3.4 Switzerland 
               11.3.4.1 Market Growth is  Primarily Driven By The Well-Established Pharmaceutical & Biotechnology Industry in The Country
             11.3.5 Italy 
               11.3.5.1 Growth in This Market is  Mainly Driven By Increasing Life Science R&D in The Country, Funded By Both Public And Private Organizations
             11.3.6 Spain 
               11.3.6.1 Spain Has A Well-Established Network of  Research Centers, Universities, And Hospitals, Which Form  an Ideal Environment for Translational Medicine Research
             11.3.7 Rest of  Europe 
     11.4 Asia Pacific  
             11.4.1 China 
               11.4.1.1 Growth in R&D to Enhance The Technological Capabilities in The Country, Thereby Driving The Demand for High-Quality Research Tools
             11.4.2 Japan 
               11.4.2.1 Large Number of  Research Initiatives Towards The Development of  Precision Medicine Supporting Market Growth in Japan
             11.4.3 India 
               11.4.3.1 Increasing Pharma R&D And Government Funding in The Biotechnology Industry are The Major Factors Driving Market Growth in India
             11.4.4 Australia 
               11.4.4.1 The Increasing Focus of  The Healthcare System On Precision Medicine to of fer Significant Growth Opportunities in Australia
             11.4.5 Rest of  Asia Pacific 
     11.5 Latin America  
             11.5.1 Brazil 
              11.5.1.1 Research Being Undertaken in The Fields of  Neuroscience, Inflammatory Diseases, And Drug Discovery, Among Other Fields to Drive Market Growth in Brazil
             11.5.2 Mexico 
             11.5.2.1 Strong Pharmaceutical Industry in The Country to Provide Significant Growth Opportunities in Mexico
             11.5.3 Rest of  Latin America 
     11.6 Middle East & Africa  
             11.6.1 Increasing Partnerships Among Global Players With Government Organizations in The Region to Support Growth of  Proteomics Research in The Middle East And Africa
 
12 Competitive Landscape  
     12.1 Overview  
     12.2 Market Share Analysis  
     12.3 Competitive Leadership Mapping  
             12.3.1 Visionary Leaders 
             12.3.2 Innovators 
             12.3.3 Dynamic Differentiators 
             12.3.4 Emerging Companies 
     12.4 Competitive Situation And Trends  
             12.4.1 Product & Services Launches 
             12.4.2 Expansions 
             12.4.3 Acquisitions 
             12.4.4 Other Strategies
 
13 Company Profiles 
     13.1 Thermo Fisher Scientific, Inc.  
     13.2 Agilent Technologies, Inc.  
     13.3 Merck Kgaa  
     13.4 Danaher Corporation  
     13.5 Waters Corporation  
     13.6 Bio-Rad Laboratories, Inc.  
     13.7 Bruker Corporation  
     13.8 Ge Healthcare  
     13.9 Perkinelmer, Inc.  
     13.1 Luminex Corporation  
     13.11 Creative Proteomics  
     13.12 Promega Corporation  
 
14 Appendix  
     14.1 Insights of  Industry Experts  
     14.2 Discussion Guide  
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal  
     14.4 Available Customizations  
     14.5 Related Reports  
     14.6 Author Details  
 
List of Tables ( 382 Tables )

Table 1 Market Drivers: Impact Analysis 
Table 2 Market Restraints: Impact Analysis 
Table 3 Market Opportunities: Impact Analysis 
Table 4 Market Challenges: Impact Analysis 
Table 5 Proteomics Market, By Product, 2017–2024 (USD Million) 
Table 6 Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 7 Proteomics Instrumentation Technology Market, By Country, 2017–2024 (USD Million)  
Table 8 Spectroscopy Market, By Type, 2017–2024 (USD Million) 
Table 9 Spectroscopy Market, By Country, 2017–2024 (USD Million) 
Table 10 Mass Spectroscopy Market, By Country, 2017–2024 (USD Million) 
Table 11 Nmr Spectroscopy Market, By Country, 2017–2024 (USD Million) 
Table 12 Cd Spectroscopy Market, By Country, 2017–2024 (USD Million) 
Table 13 Chromatography Market, By Type, 2017–2024 (USD Million) 
Table 14 Chromatography Market, By Country, 2017–2024 (USD Million) 
Table 15 Hplc Market, By Country, 2017–2024 (USD Million) 
Table 16 Ion Chromatography Market, By Country, 2017–2024 (USD Million) 
Table 17 Affinity Chromatography Market, By Country, 2017–2024 (USD Million) 
Table 18 Supercritical Fluid Chromatography Market, By Country, 2017–2024 (USD Million)  
Table 19 Electrophoresis Market, By Type, 2017–2024 (USD Million) 
Table 20 Electrophoresis Market, By Country, 2017–2024 (USD Million) 
Table 21 Gel Electrophoresis Market, By Country, 2017–2024 (USD Million) 
Table 22 Capillary Electrophoresis Market, By Country, 2017–2024 (USD Million)  
Table 23 Protein Microarrays Market, By Type, 2017–2024 (USD Million) 
Table 24 Protein Microarrays Market, By Country, 2017–2024 (USD Million) 
Table 25 Biochips Market, By Type, 2017–2024 (USD Million) 
Table 26 Biochips Market, By Country, 2017–2024 (USD Million) 
Table 27 Lab-On-Chips Market, By Country, 2017–2024 (USD Million) 
Table 28 Protein Chips Market, By Country, 2017–2024 (USD Million) 
Table 29 Microarray Instruments Market, By Type, 2017–2024 (USD Million) 
Table 30 Microarray Instruments Market, By Country, 2017–2024 (USD Million) 
Table 31 Integrated Systems Market, By Country, 2017–2024 (USD Million) 
Table 32 Microarray Scanners Market, By Country, 2017–2024 (USD Million) 
Table 33 Arrayers Market, By Country, 2017–2024 (USD Million) 
Table 34 X-Ray Crystallography Market, By Country, 2017–2024 (USD Million) 
Table 35 Surface Plasmon Resonance Market, By Country, 2017–2024 (USD Million)  
Table 36 Protein Fractionation Market, By Country, 2017–2024 (USD Million) 
Table 37 Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 38 Proteomics Market for Immunoassay Reagents, By Country, 2017–2024 (USD Million)  
Table 39 Proteomics Market for Spectroscopy Reagents, By Country, 2017–2024 (USD Million)  
Table 40 Proteomics Market for Chromatography Reagents, By Country, 2017–2024 (USD Million)  
Table 41 Proteomics Market for Protein Microarray Reagents, By Country, 2017–2024 (USD Million) 
Table 42 Proteomics Market for X-Ray Crystallography Reagents, By Country, 2017–2024 (USD Million) 
Table 43 Proteomics Market for Electrophoresis Reagents, By Country, 2017–2024 (USD Million)  
Table 44 Proteomics Market for Protein Fractionation Reagents, By Country, 2017–2024 (USD Million) 
Table 45 Proteomics Market, By Service & Software, 2017–2024 (USD Million) 
Table 46 Core Proteomics Services Market, By Type, 2017–2024 (USD Million) 
Table 47 Core Proteomics Services Market, By Country, 2017–2024 (USD Million) 
Table 48 Protein Identification Services Market, By Country, 2017–2024 (USD Million)  
Table 49 Protein Characterization Services Market, By Country, 2017–2024 (USD Million)  
Table 50 Quantitative Proteomics Services Market, By Country, 2017–2024 (USD Million)  
Table 51 Protein Purification Services Market, By Country, 2017–2024 (USD Million)  
Table 52 Protein Separation Services Market, By Country, 2017–2024 (USD Million)  
Table 53 Protein Sequencing Services Market, By Country, 2017–2024 (USD Million)  
Table 54 Custom Assay Services Market, By Country, 2017–2024 (USD Million) 
Table 55 Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 56 Bioinformatics Software & Services Market, By Country, 2017–2024 (USD Million)  
Table 57 Bioinformatics Services Market, By Country, 2017–2024 (USD Million) 
Table 58 Bioinformatics Tools Market, By Country, 2017–2024 (USD Million) 
Table 59 Bioinformatics Databases Market, By Country, 2017–2024 (USD Million) 
Table 60 Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 62 Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million)  
Table 63 Proteomics Market for Clinical Diagnostics, By Country, 2017–2024 (USD Million)  
Table 64 Proteomics Market for Cancer, By Country, 2017–2024 (USD Million)  
Table 65 Proteomics Market for Infectious Diseases, By Country, 2017–2024 (USD Million)  
Table 66 Proteomics Market for Diabetes, By Country, 2017–2024 (USD Million)  
Table 67 Proteomics Market for Neurological Disorders, By Country, 2017–2024 (USD Million)  
Table 68 Proteomics Market for Immune Diseases, By Country, 2017–2024 (USD Million)  
Table 69 Proteomics Market for Cardiovascular Diseases, By Country, 2017–2024 (USD Million)  
Table 70 Proteomics Market for Other Clinical Diagnostic Applications, By Country, 2017–2024 (USD Million) 
Table 71 Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million)  
Table 72 Proteomics Market for Drug Discovery, By Country, 2017–2024 (USD Million)  
Table 73 Proteomics Market for Target Discovery, By Country, 2017–2024 (USD Million)  
Table 74 Proteomics Market for Lead Identification, By Country, 2017–2024 (USD Million)  
Table 75 Proteomics Market for Lead Optimization, By Country, 2017–2024 (USD Million)  
Table 76 Proteomics Market for Preclinical Studies, By Country, 2017–2024 (USD Million)  
Table 77 Proteomics Market for Other Applications, By Country, 2017–2024 (USD Million)  
Table 78 Proteomics Market, By Region, 2017–2024 (USD Million) 
Table 79 North America: Proteomics Market, By Country, 2017–2024 (USD Million)  
Table 80 North America: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 81 North America: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million) 
Table 82 North America: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 83 North America: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million) 
Table 84 North America: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million) 
Table 85 North America: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 86 North America: Proteomics Market, By Reagent, 2017–2024 (USD Million)  
Table 87 North America: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 88 North America: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 89 North America: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 90 North America: Proteomics Market, By Application, 2017–2024 (USD Million)  
Table 100 North America: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 101 North America: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million)  
Table 102 Us: Proteomics Market, By Product & Service, 2017–2024 (USD Million) 
Table 103 Us: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 104 Us: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 105 Us: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 106 Us: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 107 Us: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 108 Us: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 109 Us: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 110 Us: Core Proteomics Services Market, By Type, 2017–2024 (USD Million) 
Table 111 Us: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 112 Us: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 113 Us: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 114 Us: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 115 Canada: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 116 Canada: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 117 Canada: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 118 Canada: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 119 Canada: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 120 Canada: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 121 Canada: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 122 Canada: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 123 Canada: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 124 Canada: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 125 Canada: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 126 Canada: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 127 Canada: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 128 Europe: Proteomics Market, By Country, 2017–2024 (USD Million) 
Table 129 Europe: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 130 Europe: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 131 Europe: Proteomics Market for Spectroscopy, By Type,  2017–2024 (USD Million)  
Table 132 Europe: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 133 Europe: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 134 Europe: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 135 Europe: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 136 Europe: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 137 Europe: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 138 Europe: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 139 Europe: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 140 Europe: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 141 Europe: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 142 Germany: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 143 Germany: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 144 Germany: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 145 Germany: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 146 Germany: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 147 Germany: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 148 Germany: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 149 Germany: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 150 Germany: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 151 Germany: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 152 Germany: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 153 Germany: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 154 Germany: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 155 Uk: Proteomics Market, By Product & Service, 2017–2024 (USD Million) 
Table 156 Uk: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 157 Uk: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 158 Uk: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 159 Uk: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 160 Uk: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 161 Uk: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 162 Uk: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 163 Uk: Core Proteomics Services Market, By Type, 2017–2024 (USD Million) 
Table 164 Uk: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 165 Uk: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 166 Uk: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 167 Uk: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 168 France: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 169 France: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 170 France: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 171 France: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 172 France: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 173 France: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 174 France: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 175 France: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 176 France: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 177 France: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 178 France: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 179 France: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 180 France: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 181 Switzerland: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 182 Switzerland: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million) 
Table 183 Switzerland: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 184 Switzerland: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 185 Switzerland: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 186 Switzerland: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million) 
Table 187 Switzerland: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 188 Switzerland: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 189 Switzerland: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 190 Switzerland: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 191 Switzerland: Proteomics Market, By Application, 2017–2024 (USD Million)  
Table 192 Switzerland: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 193 Switzerland: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million)  
Table 194 Italy: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 195 Italy: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 196 Italy: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 197 Italy: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 198 Italy: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 199 Italy: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 200 Italy: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 201 Italy: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 202 Italy: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 203 Italy: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 204 Italy: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 205 Italy: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 206 Italy: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 207 Spain: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 208 Spain: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 209 Spain: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 210 Spain: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 211 Spain: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 212 Spain: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 213 Spain: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 214 Spain: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 215 Spain: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 216 Spain: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 217 Spain: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 218 Spain: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 219 Spain: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 220 RoE: Proteomics Market, By Product & Service, 2017–2024 (USD Million) 
Table 221 RoE: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 222 RoE: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 223 RoE: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 224 RoE: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 225 RoE: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 226 RoE: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 227 RoE: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 228 RoE: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 229 RoE: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 230 RoE: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 231 RoE: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 232 RoE: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 233 Asia Pacific: Proteomics Market, By Country, 2017–2024 (USD Million) 
Table 234 Asia Pacific: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 235 Asia Pacific: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 236 Asia Pacific: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 237 Asia Pacific: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 238 Asia Pacific: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 239 Asia Pacific: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million) 
Table 240 Asia Pacific: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 241 Asia Pacific: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 242 Asia Pacific: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 243 Asia Pacific: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 244 Asia Pacific: Proteomics Market, By Application, 2017–2024 (USD Million)  
Table 245 Asia Pacific: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 246 Asia Pacific: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million)  
Table 247 China: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 248 China: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 249 China: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 250 China: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 251 China: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 252 China: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 253 China: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 254 China: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 255 China: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 256 China: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 257 China: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 258 China: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 259 China: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 260 Japan: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 261 Japan: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 262 Japan: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 263 Japan: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 264 Japan: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 265 Japan: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 266 Japan: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 267 Japan: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 268 Japan: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 269 Japan: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 270 Japan: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 271 Japan: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 272 Japan: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 273 India: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 274 India: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 275 India: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 276 India: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 278 India: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 279 India: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 280 India: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 281 India: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 282 India: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 283 India: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 284 India: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 285 India: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 286 India: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 287 Australia: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 288 Australia: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 289 Australia: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 290 Australia: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 291 Australia: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 292 Australia: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 293 Australia: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 294 Australia: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 295 Australia: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 296 Australia: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 297 Australia: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 298 Australia: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 299 Australia: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 300 RoAPAC: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 301 RoAPAC: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 302 RoAPAC: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 303 RoAPAC: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 304 RoAPAC: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 305 RoAPAC: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 306 RoAPAC: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 307 RoAPAC: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 308 RoAPAC: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 309 RoAPAC: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 310 RoAPAC: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 311 RoAPAC: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 312 RoAPAC: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 313 Latin America: Proteomics Market, By Country, 2017–2024 (USD Million) 
Table 314 Latin America: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 315 Latin America: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million) 
Table 316 Latin America: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 317 Latin America: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 318 Latin America: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 319 Latin America: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million) 
Table 320 Latin America: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 321 Latin America: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 322 Latin America: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 323 Latin America: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 324 Latin America: Proteomics Market, By Application, 2017–2024 (USD Million)  
Table 325 Latin America: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million)  
Table 326 Latin America: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million)  
Table 327 Brazil: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 328 Brazil: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 329 Brazil: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 330 Brazil: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 331 Brazil: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 332 Brazil: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 333 Brazil: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 334 Brazil: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 335 Brazil: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 336 Brazil: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 337 Brazil: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 338 Brazil: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 339 Brazil: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 340 Mexico: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 341 Mexico: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 342 Mexico: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 343 Mexico: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 344 Mexico: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 345 Mexico: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 346 Mexico: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 347 Mexico: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 348 Mexico: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 349 Mexico: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 350 Mexico: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 351 Mexico: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 352 Mexico: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 353 RoLA: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 354 RoLA: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million)  
Table 355 RoLA: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 356 RoLA: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 357 RoLA: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 358 RoLA: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 359 RoLA: Proteomics Market, By Reagent, 2017–2024 (USD Million) 
Table 360 RoLA: Proteomics Market, By Services & Software, 2017–2024 (USD Million)  
Table 361 RoLA: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 362 RoLA: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 363 RoLA: Proteomics Market, By Application, 2017–2024 (USD Million) 
Table 364 RoLA: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 365 RoLA: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million) 
Table 366 Middle East & Africa: Proteomics Market, By Product & Service, 2017–2024 (USD Million)  
Table 367 Middle East & Africa: Proteomics Market, By Instrumentation Technology, 2017–2024 (USD Million) 
Table 368 Middle East & Africa: Proteomics Market for Spectroscopy, By Type, 2017–2024 (USD Million)  
Table 369 Middle East & Africa: Proteomics Market for Chromatography, By Type, 2017–2024 (USD Million)  
Table 370 Middle East & Africa: Proteomics Market for Electrophoresis, By Type, 2017–2024 (USD Million)  
Table 371 Middle East & Africa: Proteomics Market for Protein Microarrays, By Type, 2017–2024 (USD Million)  
Table 372 Middle East & Africa: Proteomics Market, By Reagent, 2017–2024 (USD Million)  
Table 373 Middle East & Africa: Proteomics Market, By Services & Software, 2017–2024 (USD Million) 
Table 374 Middle East & Africa: Core Proteomics Services Market, By Type, 2017–2024 (USD Million)  
Table 375 Middle East & Africa: Bioinformatics Software & Services Market, By Type, 2017–2024 (USD Million)  
Table 376 Middle East & Africa: Proteomics Market, By Application, 2017–2024 (USD Million)  
Table 377 Middle East & Africa: Proteomics Market for Clinical Diagnostics, By Type, 2017–2024 (USD Million) 
Table 378 Middle East & Africa: Proteomics Market for Drug Discovery, By Type, 2017–2024 (USD Million)  
Table 379 Product And Service Launches, 2016–2018 
Table 380 Expansions, 2016–2018 
Table 381 Acquisitions, 2016–2018 
Table 382 Other Strategies, 2016–2018 
   
List of  Figures ( 44 Figures ) 
  
Figure 1 Proteomics Market 
Figure 2 Research Design 
Figure 3 Breakdown of  Primary Interviews: By Company Type, Designations, And Region 35 
Figure 4 Bottom-Up Approach 
Figure 5 Top-Down Approach 
Figure 6 Data Triangulation Methodology 
Figure 7 Proteomics Market, By Instrumentation Technology,   2019 Vs. 2024 (USD Million) 40 
Figure 8 Proteomics Market, By Reagent, 2019 Vs. 2024 (USD Million) 
Figure 9 Proteomics Market, By Software & Service,  2019 Vs. 2024 (USD Million) 
Figure 10 Proteomics Market, By Application, 2019 Vs. 2024 (USD Million) 
Figure 11 Geographical Snapshot of  The Proteomics Market 
Figure 12 Increasing Demand for Personalized Medicine to Drive Market Growth 
Figure 13 China to Grow  at  The Highest Cagr During The Forecast Period 
Figure 14 Apac to Register The Highest Growth Rate During The Forecast Period (2019–2024) 
Figure 15 Developing Markets to Register A Higher Growth Rate Between   2019 & 2024 48 
Figure 16 Proteomics Market: Drivers, Restraints, Opportunities, and Challenges 
Figure 17 Launch of  Personalized Medicine Products, 2008–2016 
Figure 18 R&D Investments, By Country, 2017 vs. 2018 (USD Billion) 
Figure 19 The Growing Focus On Monitoring Ptms and The Increasing Uptake of  Lfq Techniques are The Key Market Trends 
Figure 20 Protein Fractionation Segment is  Expected to Witness High Growth During The Forecast Period 
Figure 21 Immunoassay Reagents to Dominate The Proteomics Market During The Forecast Period 
Figure 22 Quantitative Proteomics Services is  Expected to Witness High Growth During The Forecast Period 
Figure 23 Bioinformatics Services Segment is  Expected to Witness High Growth During The Forecast Period 
Figure 24 Clinical Diagnostics Segment Will Continue to Dominate The Proteomics Market During The Forecast Period 
Figure 25 Incidence of  Infectious Diseases, 2015—2017 
Figure 26 R&D Investments in Life Science, 2016—2018 
Figure 27 Proteomics Market: Geographic Snapshot (2018) 
Figure 28 North America: Proteomics Market Snapshot 
Figure 29 Europe: Proteomics Market Snapshot 
Figure 30 Asia Pacific: Proteomics Market Snapshot 
Figure 31 Product Launches—Key Growth Strategy Adopted By Market Players From 2016 to January 2019 
Figure 32 Chromatography Instruments Market Share, By Key Player, 2017 
Figure 33 Mass Spectroscopy Instruments Market Share, By Key Player, 2017 
Figure 34 Proteomics Market: Competitive Leadership Mapping (2018) 
Figure 35 Thermo Fisher Scientific, Inc.: Company Snapshot 
Figure 36 Agilent Technologies, Inc.: Company Snapshot 
Figure 37 Merck Kgaa: Company Snapshot 
Figure 38 Danaher Corporation: Company Snapshot 
Figure 39 Waters Corporation: Company Snapshot 
Figure 40 Bio-Rad Laboratories, Inc.: Company Snapshot 
Figure 41 Bruker Corporation: Company Snapshot 
Figure 42 GE Healthcare: Company Snapshot 
Figure 43 Perkinelmer: Company Snapshot 
Figure 44 Luminex Corporation: Company Snapshot 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the proteomics market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the proteomics market. The primary sources from the demand side included industry experts, such as researchers and scientists, and industry experts from pharmaceutical & biotechnology companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Proteomics Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, end user, and region).

Data Triangulation

After arriving at the market size, the proteomics market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, segment, and forecast the global proteomics market by instrumentation technology, reagent, services and software, application, end user, and region.
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the proteomics market in five main regions along with their respective key countries (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa)
  • To profile key players in the global proteomics market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, & agreements; and R&D activities of the leading players in the proteomics market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players

Geographic Analysis

  • A further breakdown of the Rest of Asia Pacific proteomics market into South Korea, New Zealand, and other South East Asian countries
  • A further breakdown of the European proteomics market into Belgium, Netherlands, and Rest of Europe.
Report Code
BT 2341
Published ON
Oct, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Proteomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home